Alembic Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
ALEMBICLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.2 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alembic Limited reported consolidated revenue from operations of ₹7,434 lakhs for Q3 FY26, up from ₹5,586 lakhs in the previous quarter and ₹5,792 lakhs in Q3 FY25. For the nine-month period, consolidated revenue grew about 11% to ₹17,995 lakhs (from ₹16,162 lakhs). Consolidated net profit (including share of associate Alembic Pharmaceuticals) for the nine months was ₹25,026 lakhs versus ₹24,223 lakhs last year, a modest ~3% rise, with EPS at ₹9.75 (vs ₹9.43). Standalone nine-month revenue rose ~12% to ₹17,420 lakhs, but standalone net profit dipped ~3.5% to ₹11,501 lakhs. The API business stood out with ~50% revenue growth in the nine-month period, while the real estate segment grew about 4%. The auditor included an Emphasis of Matter on a pending electricity duty dispute (₹2,052 lakhs principal provisioned, additional interest as contingent liability, and ₹35 crore already deposited with the Supreme Court). The company also booked an extra ₹143.72 lakhs provision for the newly notified Labour Codes.
Results are mixed — top-line growth is healthy, especially in the API segment, but bottom-line growth is muted and standalone profits actually declined slightly. The ongoing electricity duty litigation remains a key overhang, though the auditor's opinion is unmodified. Expect a neutral-to-mildly positive market reaction, with focus on the strong API performance.